SPDR S&P Pharmaceuticals ETF
XPH
XPH
72 hedge funds and large institutions have $138M invested in SPDR S&P Pharmaceuticals ETF in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 11 closing their positions.
Holders
72
Holders Change
+8
Holders Change %
+12.5%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
16
Reduced
18
Closed
11
Calls
$649K
Puts
$1.01M
Net Calls
-$358K
Net Calls Change
+$934K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$32.5M |
2 |
2
Bank of America
Charlotte,
North Carolina
|
$23.1M |
3 |
3
Wells Fargo
San Francisco,
California
|
$6.73M |
4 |
4
BNP Paribas Financial Markets
Paris,
France
|
$2.36M |
5 |
TCA
5
Taconic Capital Advisors
New York
|
$1.66M |